Clearside Biomedical Share Price Today
(NASDAQ: CLSD)

Name: Clearside Biomedical Share Price Today (NASDAQ: CLSD) - Clearside Biomedical Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Clearside Biomedical share price is $0.84 & ₹73.05 as on 6 Mar 2025, 2.30 'hrs' IST

$0.84

▲

0.04

(5%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Clearside Biomedical share price in Dollar and Rupees. Guide to invest in Clearside Biomedical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Clearside Biomedical, along with analyst recommendations, forecasts, and comprehensive financials.

Clearside Biomedical share price movements

Today's Low: $0.79
Today's High: $0.85
$0.84
5.95%
Downside
Day's Volatility :7.36%
Upside
1.5%
52 Weeks Low: $0.77
52 Weeks High: $2.12
$0.84
7.89%
Downside
52 Weeks Volatility :63.5%
Upside
60.38%

Clearside Biomedical (CLSD) Returns

Period	Clearside Biomedical Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-23.08%	2.1%	0.0%
6 Months	-13.74%	-4.1%	0.0%
1 Year	-47.02%	2.2%	0.0%
3 Years	-41.18%	11.8%	-11.6%

Clearside Biomedical (CLSD) Key Statistics

in dollars & INR

Previous Close	$0.8
Open	$0.81
Today's High	$0.8528
Today's Low	$0.79
Market Capitalization	$60.1M
Today's Volume	$93.4K
52 Week High	$2.12
52 Week Low	$0.7737
Revenue TTM	$7.7M
EBITDA	$-24.5M
Earnings Per Share (EPS)	$-0.45
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1310.02%

How to invest in Clearside Biomedical Stock (CLSD) from India?

It is very easy for Indian residents to invest directly in Clearside Biomedical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Clearside Biomedical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Clearside Biomedical or CLSD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Clearside Biomedical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Clearside Biomedical shares which would translate to 1.035 fractional shares of Clearside Biomedical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Clearside Biomedical, in just a few clicks!

Returns in Clearside Biomedical (CLSD) for Indian investors in Rupees

The Clearside Biomedical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Clearside Biomedical investment value today

Current value as on today

₹60,592

Returns

₹39,408

(-39.41%)

Returns from Clearside Biomedical Stock

₹44,371 (-44.37%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Clearside Biomedical (CLSD)

-55%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Clearside Biomedical Stock from India on INDmoney has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Clearside Biomedical

Vanguard Group Inc
3.70%
Carmignac Gestion
2.55%
BlackRock Inc
1.16%
Geode Capital Management, LLC
1.01%
Renaissance Technologies Corp
0.95%
First Manhattan Co. LLC
0.53%

Analyst Recommendation on Clearside Biomedical

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Clearside Biomedical(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Clearside Biomedical Stock (CLSD)

What analysts predicted

Upside of 614.29%

Target:

$6.00

Current:

$0.84

Insights on Clearside Biomedical Stock (Ticker Symbol: CLSD)

Price Movement
In the last 7 days, CLSD stock has moved down by -11.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 90.0K → 1.03M (in $), with an average increase of 91.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -7.59M → -7.68M (in $), with an average decrease of 1.2% per quarter
CLSD vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 104.7%
CLSD vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 90.1%
Price to Sales
ForCLSD every $1 of sales, investors are willing to pay $7.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

CLSD Clearside Biomedical Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$30.0K	↓ 91.3%
Net Income	$-82.8M	↑ 40.43%
Net Profit Margin	-276.1K%	↓ 258965.8%

	FY19	Y/Y Change
Revenue	$2.2M	↑ 7143.33%
Net Income	$-30.6M	↓ 63.1%
Net Profit Margin	-1.4K%	↑ 274653.7%

	FY20	Y/Y Change
Revenue	$7.9M	↑ 263.28%
Net Income	$-18.0M	↓ 41.0%
Net Profit Margin	-228.4%	↑ 1177.9%

	FY21	Y/Y Change
Revenue	$29.6M	↑ 274.65%
Net Income	$376.0K	↓ 102.09%
Net Profit Margin	1.27%	↑ 229.67%

	FY22	Y/Y Change
Revenue	$1.3M	↓ 95.51%
Net Income	$-34.1M	↓ 9161.53%
Net Profit Margin	-2.6K%	↓ 2568.82%

	FY23	Y/Y Change
Revenue	$8.2M	↑ 519.89%
Net Income	$-32.5M	↓ 4.66%
Net Profit Margin	-394.91%	↑ 2172.64%

	Q2 FY23	Q/Q Change
Revenue	$1.0M	↑ 25350.0%
Net Income	$-9.1M	↓ 30.61%
Net Profit Margin	-894.5%	↑ 327155.5%

	Q3 FY23	Q/Q Change
Revenue	$859.0K	↓ 15.62%
Net Income	$-9.3M	↑ 1.77%
Net Profit Margin	-1.1K%	↓ 184.31%

	Q4 FY23	Q/Q Change
Revenue	$6.3M	↑ 638.65%
Net Income	$-4.8M	↓ 47.86%
Net Profit Margin	-76.15%	↑ 1002.66%

	Q1 FY24	Q/Q Change
Revenue	$230.0K	↓ 96.38%
Net Income	$-11.8M	↑ 143.44%
Net Profit Margin	-5.1K%	↓ 5038.2%

	Q2 FY24	Q/Q Change
Revenue	$90.0K	↓ 60.87%
Net Income	$-7.6M	↓ 35.44%
Net Profit Margin	-8.4K%	↓ 3323.43%

	Q3 FY24	Q/Q Change
Revenue	$1.0M	↑ 1053.33%
Net Income	$-7.7M	↑ 1.24%
Net Profit Margin	-740.66%	↑ 7697.12%

	FY18	Y/Y Change
Profit	$30.0K	↓ 91.3%

	FY19	Y/Y Change
Profit	$2.2M	↑ 7143.33%

	FY20	Y/Y Change
Profit	$7.9M	↑ 263.28%

	FY21	Y/Y Change
Profit	$29.4M	↑ 272.4%

	FY22	Y/Y Change
Profit	$1.1M	↓ 96.18%

	FY23	Y/Y Change
Profit	$7.9M	↑ 600.89%

	Q2 FY23	Q/Q Change
Profit	$805.0K	↓ 7418.18%

	Q3 FY23	Q/Q Change
Profit	$717.0K	↓ 10.93%

	Q4 FY23	Q/Q Change
Profit	$6.3M	↑ 782.15%

	Q1 FY24	Q/Q Change
Profit	$202.0K	↓ 96.81%

	Q2 FY24	Q/Q Change
Profit	$90.0K	↓ 55.45%

	Q3 FY24	Q/Q Change
Profit	$1.0M	↑ 1053.33%

	FY18	Y/Y Change
Operating Cash Flow	$-79.2M	↑ 55.04%
Investing Cash Flow	$-3.8M	↓ 118.69%
Financing Cash Flow	$81.8M	↑ 1425.16%

	FY19	Y/Y Change
Operating Cash Flow	$-27.1M	↓ 65.82%
Investing Cash Flow	$32.9M	↓ 975.66%
Financing Cash Flow	$8.7M	↓ 89.37%

	FY20	Y/Y Change
Operating Cash Flow	$-13.1M	↓ 51.53%
Investing Cash Flow	$-55.0K	↓ 100.17%
Financing Cash Flow	$7.9M	↓ 9.52%

	FY21	Y/Y Change
Operating Cash Flow	$-10.7M	↓ 18.19%
Investing Cash Flow	$-246.0K	↑ 347.27%
Financing Cash Flow	$23.8M	↑ 202.3%

	FY22	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 24.52%
Investing Cash Flow	$-246.0K	↑ 0.0%
Financing Cash Flow	$31.3M	↑ 31.75%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.3M	↓ 26.01%
Investing Cash Flow	$-1.1M	↑ 853.91%
Financing Cash Flow	$22.0K	↓ 93.37%

Clearside Biomedical Technicals Summary

Sell

Neutral

Buy

Clearside Biomedical is currently in a neutral trading position according to technical analysis indicators.

Clearside Biomedical (CLSD) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Clearside Biomedical Inc	-14.89%	-13.74%	-47.02%	-41.18%	-85.48%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Clearside Biomedical Inc	133.0	NA	0.0	-0.47	-13.1	-0.48	NA	-0.46
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Clearside Biomedical Inc	Buy	$60.1M	-85.48%	133.0	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Clearside Biomedical

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Organization	Clearside Biomedical
Employees	30
CEO	Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Industry	Health Technology

Management People of Clearside Biomedical

Name	Title
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.	President, CEO & Director
Mr. Charles A. Deignan	Chief Financial Officer
Ms. Jenny R. Kobin	Head of Investor Relations
Mr. Rick McElheny	Senior Vice President of Corporate Development & Alliance Management
Mr. Rafael V. Andino	Senior Vice President of Engineering & Manufacturing
Ms. Susan L. Coultas Ph.D.	Chief Clinical Officer
Dr. Ngai Hang Chong FRCOphth, FRCS, M.B.A., M.D.	Chief Medical Officer
Mr. Leslie B. Zacks J.D.	Secretary

Important FAQs about investing in CLSD Stock from India :

What is Clearside Biomedical share price today?

Clearside Biomedical share price today stands at $0.84, Open: $0.81 ; Previous Close: $0.80 ; High: $0.85 ; Low: $0.79 ; 52 Week High: $2.12 ; 52 Week Low: $0.77.

The stock opens at $0.81, after a previous close of $0.80. The stock reached a daily high of $0.85 and a low of $0.79, with a 52-week high of $2.12 and a 52-week low of $0.77.

Can Indians buy Clearside Biomedical shares?

Yes, Indians can invest in the Clearside Biomedical (CLSD) from India.

With INDmoney, you can buy Clearside Biomedical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Clearside Biomedical at zero transaction cost.

How can I buy Clearside Biomedical shares from India?

It is very easy to buy Clearside Biomedical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Clearside Biomedical (CLSD) be purchased?

Yes, you can buy fractional shares of Clearside Biomedical with INDmoney app.

What are the documents required to start investing in Clearside Biomedical stocks?

To start investing in Clearside Biomedical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.